SCHEMBL93511

SCHEMBL93511

CN1CCN(c2ccc(Nc3ncc(Cl)c(Oc4cccc(C=CC(N)=O)c4)n3)cc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.69
JAK2 O60674 2/20 0.69
BLK P51451 2/20 0.69
BMX P51813 2/20 0.69
JAK3 P52333 2/20 0.69
CTSC P53634 3/20 0.65
MAP3K7 O43318 3/20 0.58
MAP2K1 Q02750 3/20 0.58
FLT3 P36888 2/20 0.58
MAPK1 P28482 1/20 0.58
NUAK1 O60285 2/20 0.55
NUAK2 Q9H093 2/20 0.55
PLK4 O00444 1/20 0.55
GAK O14976 1/20 0.55
PTK2 Q05397 1/20 0.55
BTK Q06187 1/20 0.55
ITK Q08881 1/20 0.55
ERBB4 Q15303 1/20 0.55
DCLK3 Q9C098 1/20 0.55
EML4 Q9HC35 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19970912 0.90 EGFR (0.68) EGFRJAK2BLKBMXJAK3
SCHEMBL15453488 0.83 EGFR (0.70) EGFRJAK2BLKBMXJAK3
SCHEMBL93524 0.82 MAP3K7 (0.57) EGFRJAK2BLKBMXJAK3
SCHEMBL93510 0.82 EGFR (1.00) EGFRJAK2BLKBMXJAK3
SCHEMBL30854720 0.82 EGFR (1.00) EGFRJAK2BLKBMXJAK3
SCHEMBL29351880 0.82 EGFR (1.00) EGFRJAK2BLKBMXJAK3
SCHEMBL10127917 0.80 CTSC (0.71) EGFRJAK2BLKBMXJAK3
SCHEMBL10127853 0.79 EGFR (0.81) EGFRJAK2BLKBMXJAK3
SCHEMBL16513550 0.79 BRD4 (0.53) EGFRJAK2BLKBMXJAK3
SCHEMBL1706135 0.77 EGFR (0.72) EGFRJAK2BLKBMXJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2425830-A1 Synergistic drug combination for the treatment of cancer Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2012-03-07 EP disclosed